Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06550453
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-02
Brief Title:
Safety and Efficacy of Pembrolizumab in Combination With Bevacizumab CapeOX in the Neoadjuvant Treatment of RAS-mutated BRAF Wild-type Microsatellite-stabilized Locally Advanced Colorectal Cancer
Sponsor:
None
Organization:
None
Key Dates - Follows AllAPIJSON File Order
Start Date:
None
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2024-08-02
First Submit QC Date:
None
Study First Post Date:
None
Study First Post Date Type:
None
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-10
Last Update Post Date:
None
Last Update Post Date Type:
None